Elevai Labs Inc.
ELAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.21M
Close$
$0.50
57.6% downside
Current Fair Value
57.6% downsideOvervalued by 57.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.21 Million |
|---|---|
| Enterprise Value | $9.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-378.74 |
| Beta | -0.28 |
| Outstanding Shares | 444,506 |
Return
| Return on Equity | 88.55% |
|---|---|
| Return on Assets | 70.26% |
| Return on Invested Capital | 125.96% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.59 |
| Price to Book Ratio | 0.3 |
| Enterprise Value to Revenue | 7.19 |
| Enterprise Value to EBIT | -0.82 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.83 |
| Debt to Equity | 3.99 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 648.25%▲ 648.25% |
|---|---|
| Total Invested | $388,302 |
| Investors Holding | 6▲ 6.00% |
ESG Score
No data